These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 33724086)

  • 1. Chagas disease is an independent predictor of stroke and death in a cohort of heart failure patients.
    Cerqueira-Silva T; Gonçalves BM; Pereira CB; Porto LM; Marques ME; Santos LS; Oliveira MA; Félix IF; de Sousa PRP; Muiños PJ; Maia RM; Catto MB; Andrade AL; Jesus PA; Aras R; Oliveira-Filho J
    Int J Stroke; 2022 Feb; 17(2):180-188. PubMed ID: 33724086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chagas disease is associated with a worse prognosis at 1-year follow-up after implantable cardioverter-defibrillator for secondary prevention in heart failure patients.
    Vieira de Melo RM; de Azevedo DFC; Lira YM; Cardoso de Oliveira NF; Passos LCS
    J Cardiovasc Electrophysiol; 2019 Nov; 30(11):2448-2452. PubMed ID: 31502385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Muscle mass, muscle strength, and functional capacity in patients with heart failure of Chagas disease and other aetiologies.
    Fonseca GWPD; Garfias Macedo T; Ebner N; Dos Santos MR; de Souza FR; Mady C; Takayama L; Pereira RMR; Doehner W; Anker SD; Negrão CE; Alves MJNN; von Haehling S
    ESC Heart Fail; 2020 Oct; 7(5):3086-3094. PubMed ID: 32860353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology of Left Ventricular Systolic Dysfunction and Heart Failure in the Framingham Study: An Echocardiographic Study Over 3 Decades.
    Vasan RS; Xanthakis V; Lyass A; Andersson C; Tsao C; Cheng S; Aragam J; Benjamin EJ; Larson MG
    JACC Cardiovasc Imaging; 2018 Jan; 11(1):1-11. PubMed ID: 28917679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The course of patients with Chagas heart disease during episodes of decompensated heart failure.
    Issa VS; Ayub-Ferreira SM; Schroyens M; Chizzola PR; Soares PR; Lage SHG; Bocchi EA
    ESC Heart Fail; 2021 Apr; 8(2):1460-1471. PubMed ID: 33595916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left Ventricular Ejection Fraction and Risk of Stroke and Cardiac Events in Heart Failure: Data From the Warfarin Versus Aspirin in Reduced Ejection Fraction Trial.
    Di Tullio MR; Qian M; Thompson JL; Labovitz AJ; Mann DL; Sacco RL; Pullicino PM; Freudenberger RS; Teerlink JR; Graham S; Lip GY; Levin B; Mohr JP; Buchsbaum R; Estol CJ; Lok DJ; Ponikowski P; Anker SD; Homma S;
    Stroke; 2016 Aug; 47(8):2031-7. PubMed ID: 27354224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chagas disease stroke and associated risk factors: A case-control study.
    de Melo ES; de Paiva Bezerra R; de Holanda AC; Lira E Silva MJ; Travassos PP; da Silva TFL; de Azevedo Oliveira GM; Alves SMM; Medeiros CA; da Silveira Barros MDND; de Oliveira WA; Silva GS; de Andrade Valença LPA
    J Stroke Cerebrovasc Dis; 2024 Jan; 33(1):107463. PubMed ID: 38006768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Left Ventricular Ejection Fraction and Clinically Defined Heart Failure to Predict 90-Day Functional Outcome After Ischemic Stroke.
    Li Y; Fitzgibbons TP; McManus DD; Goddeau RP; Silver B; Henninger N
    J Stroke Cerebrovasc Dis; 2019 Feb; 28(2):371-380. PubMed ID: 30396839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stroke history and Chagas disease are independent predictors of silent cerebral microembolism in patients with congestive heart failure.
    Jesus PA; Neville I; Cincurá C; Menezes DF; Vieira-de-Melo RM; Lacerda AM; Viana LC; Pereira DF; Ribeiro-dos-Santos V; Reis FJ; Macedo C; Oliveira-Filho J
    Cerebrovasc Dis; 2011; 31(1):19-23. PubMed ID: 20980749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contemporary Characteristics and Outcomes in Chagasic Heart Failure Compared With Other Nonischemic and Ischemic Cardiomyopathy.
    Shen L; Ramires F; Martinez F; Bodanese LC; Echeverría LE; Gómez EA; Abraham WT; Dickstein K; Køber L; Packer M; Rouleau JL; Solomon SD; Swedberg K; Zile MR; Jhund PS; Gimpelewicz CR; McMurray JJV;
    Circ Heart Fail; 2017 Nov; 10(11):. PubMed ID: 29141857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of cardiac and extra-cardiac disease burden to risk of cardiovascular outcomes varies by ejection fraction in heart failure.
    Wolsk E; Claggett B; Køber L; Pocock S; Yusuf S; Swedberg K; McMurray JJV; Granger CB; Pfeffer MA; Solomon SD
    Eur J Heart Fail; 2018 Mar; 20(3):504-510. PubMed ID: 29193462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mini Nutritional Assessment Short Form is a morbi-mortality predictor in outpatients with heart failure and mid-range left ventricular ejection fraction.
    Joaquín C; Alonso N; Lupón J; de Antonio M; Domingo M; Moliner P; Zamora E; Codina P; Ramos A; González B; Rivas C; Cachero M; Puig-Domingo M; Bayes-Genis A
    Clin Nutr; 2020 Nov; 39(11):3395-3401. PubMed ID: 32169324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Independent and cumulative association of clinical and morphological heart failure with long-term outcome after percutaneous coronary intervention.
    Kimura M; Kohno T; Sawano M; Heidenreich PA; Ueda I; Takahashi T; Matsubara T; Ueno K; Hayashida K; Yuasa S; Ohki T; Fukuda K; Kohsaka S
    J Cardiol; 2021 Jan; 77(1):41-47. PubMed ID: 32888830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Left Ventricular Systolic Function With Incident Heart Failure in Late Life.
    Reimer Jensen AM; Zierath R; Claggett B; Skali H; Solomon SD; Matsushita K; Konety S; Butler K; Kitzman DW; Biering-Sørensen T; Shah AM
    JAMA Cardiol; 2021 May; 6(5):509-520. PubMed ID: 33729428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Atrial Fibrillation on Mortality, Stroke Risk, and Quality-of-Life Scores in Patients With Heart Failure (from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation [ORBIT-AF]).
    Cherian TS; Shrader P; Fonarow GC; Allen LA; Piccini JP; Peterson ED; Thomas L; Kowey PR; Gersh BJ; Mahaffey KW
    Am J Cardiol; 2017 Jun; 119(11):1763-1769. PubMed ID: 28416199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Echocardiographic Features of Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction.
    Shah AM; Cikes M; Prasad N; Li G; Getchevski S; Claggett B; Rizkala A; Lukashevich I; O'Meara E; Ryan JJ; Shah SJ; Mullens W; Zile MR; Lam CSP; McMurray JJV; Solomon SD;
    J Am Coll Cardiol; 2019 Dec; 74(23):2858-2873. PubMed ID: 31806129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heart Failure and Midrange Ejection Fraction: Implications of Recovered Ejection Fraction for Exercise Tolerance and Outcomes.
    Nadruz W; West E; Santos M; Skali H; Groarke JD; Forman DE; Shah AM
    Circ Heart Fail; 2016 Apr; 9(4):e002826. PubMed ID: 27009553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of gender on heart failure presentation in non-obstructive hypertrophic cardiomyopathy.
    Jang JH; Shin SH; Beak YS; Ko KY; Kwon SW; Park SD; Woo SI; Kim DH; Kwan J
    Heart Vessels; 2020 Feb; 35(2):214-222. PubMed ID: 31482215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of the CALL Risk Score for predicting mortality in Brazilian heart failure patients.
    Nakazone MA; Otaviano AP; Machado MN; Bestetti RB
    ESC Heart Fail; 2020 Oct; 7(5):2331-2339. PubMed ID: 32608119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of ejection fraction on the prognostic value of sympathetic innervation imaging with iodine-123 MIBG in heart failure.
    Shah AM; Bourgoun M; Narula J; Jacobson AF; Solomon SD
    JACC Cardiovasc Imaging; 2012 Nov; 5(11):1139-46. PubMed ID: 23153914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.